Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Fiona McNicholas is active.

Publication


Featured researches published by Fiona McNicholas.


Neuropsychologia | 2008

Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD

Katherine A. Johnson; Mark A. Bellgrove; Marie Cox; Simon P. Kelly; Aoife Dáibhis; Michael Daly; Michelle Keavey; Amy Watchorn; Michael Fitzgerald; Fiona McNicholas; Aiveen Kirley; Ian H. Robertson; Michael Gill

Increased variability in reaction time (RT) has been proposed as a cardinal feature of attention deficit hyperactivity disorder (ADHD). Increased variability during sustained attention tasks may reflect inefficient fronto-striatal and fronto-parietal circuitry; activity within these circuits is modulated by the catecholamines. A disruption to dopamine signaling is suggested in ADHD that may be ameliorated by methylphenidate (MPH). This study investigated the effects of MPH administration on the variability in RT and error performance on a sustained attention task of a group of 31 medication naïve children with ADHD, compared with 22 non-ADHD, non-medicated, control children. All children performed the fixed-sequence sustained attention to response task (SART) at two time-points: at baseline and after six weeks. The children with ADHD were tested when medication naive at baseline and after six weeks of treatment with MPH and whilst on medication. The medication naïve children with ADHD performed the SART with greater errors of commission and omission when compared with the control group. They demonstrated greater standard deviation of RT and fast moment-to-moment variability. They did not differ significantly from the control group in terms of slow variability in RT. MPH administration resulted in reduced and normalised levels of commission errors and fast, moment-to-moment variability in RT. MPH did not affect the rate of omission errors, standard deviation of RT or slow frequency variability in RT. MPH administration may have a specific effect on those performance components that reflect sustained attention and top-down control rather than arousal.


Neuropsychopharmacology | 2008

Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD

Mark A. Bellgrove; Katherine A. Johnson; Marie Cox; Aoife Dáibhis; Michael Daly; Ziarih Hawi; David Lambert; Michael Fitzgerald; Fiona McNicholas; Ian H. Robertson; Michael Gill; Aiveen Kirley

Attention-deficit hyperactivity disorder (ADHD) is a heritable childhood onset disorder that is marked by variability at multiple levels including clinical presentation, cognitive profile, and response to stimulant medications. It has been suggested that this variability may reflect etiological differences, particularly, at the level of underlying genetics. This study examined whether an attentional phenotype-spatial attentional bias could serve as a marker of symptom severity, genetic risk, and stimulant response in ADHD. A total of 96 children and adolescents with ADHD were assessed on the Landmark Task, which is a sensitive measure of spatial attentional bias. All children were genotyped for polymorphisms (3′ untranslated (UTR) and intron 8 variable number of tandem repeats (VNTRs)) of the dopamine transporter gene (DAT1). Spatial attentional bias correlated with ADHD symptom levels and varied according to DAT1 genotype. Children who were homozygous for the 10-repeat allele of the DAT1 3′-UTR VNTR displayed a rightward attentional bias and had higher symptom levels compared to those with the low-risk genotype. A total of 26 of these children who were medication naive performed the Landmark Task at baseline and then again after 6 weeks of stimulant medication. Left-sided inattention (rightward bias) at baseline was associated with an enhanced response to stimulants at 6 weeks. Moreover, changes in spatial bias with stimulant medications, varied as a function of DAT1 genotype. This study suggests an attentional phenotype that relates to symptom severity and genetic risk for ADHD, and may have utility in predicting stimulant response in ADHD.


European Child & Adolescent Psychiatry | 2008

'More than 100 years of silence', elective mutism: a review of the literature.

Louise Sharkey; Fiona McNicholas

Elective mutism is a rare disorder of communication, where the child speaks fluently in familiar situations, such as home, despite lack of speech in less familiar settings, for example school. A variety of temperamental and behaviour characteristics, co-morbid psychiatric conditions, neurodevelopmental delay and family factors have been associated with the disorder. EM children are described as excessively shy, withdrawn, ‘slow to warm up’, inhibited, often avoid eye contact, fear social embarrassment and experience significant separation anxiety, on separation from their attachment figures. Their behaviour is often perceived by others as controlling and oppositional. Onset of EM is typically in early childhood years. A number of constitutional and environmental factors have been considered in its onset, progression and response to intervention. Treatment is generally considered to be multimodal, and occurs in a variety of settings, including home and school. Longterm studies suggest that communication difficulties may extend into adulthood. In addition, outcome studies showing a high rate of phobic disorders suggest that EM may be a developmental precursor of adult social phobia. This article reviews the literature on EM, its presentation, aetiology, epidemiology and the various evidence based biopsychosocial treatments.


Early Intervention in Psychiatry | 2014

Transition from child and adolescent to adult mental health services in the Republic of Ireland: an investigation of process and operational practice

Niamh McNamara; Fiona McNicholas; Tamsin Ford; Moli Paul; Blanaid Gavin; Imelda Coyne; Walter Cullen; Karen O'Connor; Nicolas Ramperti; Barbara Dooley; Siobhan Barry; Swaran P. Singh

Ensuring a seamless transition from child to adult mental health services poses challenges for services worldwide. This is an important process in the ongoing care of young people with mental illness; therefore, it is incumbent on all countries to probe their individual structures to assess the quality of mental health service delivery to this vulnerable cohort. To date, there have been no published studies on the transition from Child to Adult Mental Health Services in the Republic of Ireland. To this end, a nationwide survey of transition policies of community mental health teams in both services was conducted in order to compare best practice guidelines for transition with current process and experience in clinical practice.


European Eating Disorders Review | 2012

The impact of self-reported pubertal status and pubertal timing on disordered eating in Irish adolescents.

Fiona McNicholas; Barbara Dooley; Niamh McNamara; Ruth Lennon

This paper considers the impact of pubertal status and pubertal timing on disordered eating in Irish adolescents. 1190 boys and 1841 girls completed the Eating Attitudes Test-26, the Eating Disorder Inventory-III and self-report measures of pubertal status and pubertal timing. Regarding pubertal status, greater maturity in girls was associated with increased overall eating concerns, higher drive for thinness and higher levels of body dissatisfaction. In boys, greater maturity was associated with lower drive for thinness and lower body dissatisfaction. Regarding pubertal timing, early-maturing girls showed the most eating concerns, the highest drive for thinness, scored highest on bulimic symptoms and were the most dissatisfied with their bodies. In contrast, late-maturing boys had more bulimic symptoms and more dissatisfaction with their bodies than on-time peers. The findings suggest that puberty itself is a risk factor for disordered eating for girls rather than boys; however, pubertal timing is a risk factor for both.


European Child & Adolescent Psychiatry | 2007

The QT interval and psychotropic medications in children : Recommendations for clinicians

Paul McNally; Fiona McNicholas; Paul Oslizlok

The use of psychotropic medications in children has increased significantly in the last few years. There have been several case reports of sudden death in children taking specific psychotropic medications. Fears that these deaths might have been caused by ventricular arrhythmias have been enhanced by reports of electrocardiographic abnormalities, including prolongation of the QTc interval, in patients taking these medications. Several factors including genetic susceptibility, pre-existing cardiac disease, abnormalities of drug clearance and concomitant use of other medications known to affect the QTc interval can increase the susceptibility of the heart to conduction abnormalities. This article discusses the potential of particular psychotropic drugs to prolong the QTc interval in children, and examines other factors that may contribute to conduction abnormalities. We aim to provide clear clinical recommendations for the prescription of these drugs and the monitoring of children taking them.


The Lancet Psychiatry | 2017

Architecture and functioning of child and adolescent mental health services: a 28-country survey in Europe

Giulia Signorini; Swaran P. Singh; Vlatka Boricevic-Marsanic; Gwen Dieleman; Katarina Dodig-Ćurković; Tomislav Franić; Suzanne E. Gerritsen; Jim E. Griffin; Athanasios Maras; Fiona McNicholas; Lesley O'Hara; Diane Purper-Ouakil; Moli Paul; Ulrike M. E. Schulze; Catherine Street; Sabine Tremmery; Helena Tuomainen; Frank C. Verhulst; Jane Warwick; Giovanni de Girolamo

The WHO Child and Adolescent Mental Health Atlas, published in 2005, reported that child and adolescent mental health services (CAMHS) in Europe differed substantially in their architecture and functioning. We assessed the characteristics of national CAMHS across the European Union (EU), including legal aspects of adolescent care. Using an online mapping survey aimed at expert(s) in each country, we obtained data for all 28 countries in the EU. The characteristics and activities of CAMHS (ie, availability of services, inpatient beds, and clinicians and organisations, and delivery of specific CAMHS services and treatments) varied considerably between countries, as did funding sources and user access. Neurodevelopmental disorders were the most frequent diagnostic group (up to 81%) for people seen at CAMHS (data available from only 13 [46%] countries). 20 (70%) countries reported having an official national child and adolescent mental health policy, covering young people until their official age of transition to adulthood. The heterogeneity in resource allocation did not seem to match epidemiological burden. Substantial improvements in the planning, monitoring, and delivery of mental health services for children and adolescents are needed.


European Child & Adolescent Psychiatry | 2012

To adhere or not, and what we can do to help

Fiona McNicholas

Two factors predict treatment outcome, how effective the treatment is and whether the patient takes or follows the treatment plan. As clinicians or scientists, we strive to develop newer and more effective treatments, both pharmacological and non-pharmacological to improve treatment outcome in our patient population. Adherence is the single most modifiable factor associated with treatment outcome, yet how often is the issue of adherence addressed in clinical consultations? The best treatment is rendered useless if not adhered to. Initial adherence rates are low and get worse with time, but methodological difficulties in studies make it difficult to determine both the clinical implication of suboptimal adherence and successful strategies. Further research should apply more rigour to the area of definition and measurement, be sufficiently powered and long term, and measure possible confounders, to allow for an understanding on the link and impact between adherence and clinical outcome. This article reviews some of the main issues with regard to adherence and cost implications of suboptimal adherence and suggests future directions.


European Child & Adolescent Psychiatry | 2003

Childhood onset narcolepsy

Laura Mckenna; Fiona McNicholas

Abstract. Narcolepsy is a disorder of the sleep-wake cycle with long-term sequelae. Although regarded as rare, it is probably under-diagnosed in both adults and children. Clinical heterogeneity, particularly in childhood, and development of symptoms over time, contribute to the delay in diagnosis and treatment. We present a case of a child with symptoms suggestive of narcolepsy. We discuss the merits of early intervention in selected cases, even when full diagnostic criteria are lacking.


Early Intervention in Psychiatry | 2012

Can general practice help address youth mental health? A retrospective cross-sectional study in Dublin's south inner city

D Connolly; Dorothy Leahy; Gerard Bury; Blanaid Gavin; Fiona McNicholas; David Meagher; F. D. O'Kelly; P Wiehe; Walter Cullen

Aims: With general practice potentially having an important role in early intervention of mental and substance use disorders among young people, we aim to explore this issue by determining the prevalence of psychological problems and general practice/health service utilization among young people attending general practice.

Collaboration


Dive into the Fiona McNicholas's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Barbara Dooley

University College Dublin

View shared research outputs
Top Co-Authors

Avatar

Walter Cullen

University College Dublin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Niamh McNamara

Nottingham Trent University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Moli Paul

University of Warwick

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gerard Bury

University College Dublin

View shared research outputs
Researchain Logo
Decentralizing Knowledge